Infective endocarditis in injection drug users
- Daniel J Sexton, MD
Daniel J Sexton, MD
- Editor-in-Chief — Infectious Diseases
- Section Editor — Bacterial Infections
- Professor of Medicine
- Duke University Medical Center
- Vivian H Chu, MD, MHS
Vivian H Chu, MD, MHS
- Associate Professor of Medicine
- Duke University Medical Center
Infective endocarditis (IE) was initially recognized to be a complication of injection drug use in the 1950s . Aspects of IE that are unique to or characteristic of injection drug users will be reviewed here. Diagnostic criteria, complications, and general management of IE are discussed separately. (See "Clinical manifestations and evaluation of adults with suspected native valve endocarditis" and "Complications and outcome of infective endocarditis" and "Antimicrobial therapy of native valve endocarditis".)
Estimates of the incidence of infective endocarditis (IE) in injection drug users (IDUs) have been hampered by the lack of reliable data; approximately 2 to 4 cases per 1000 years of IDU have been described [2-4]. IE among IDUs is more common in males (ratio 3:1) . The average age of patients with IE and IDU is generally younger than for the age of patients with IE and no history of IDU (31 versus 42 years in one study) .
The local or regional incidence of IDU has had an impact on the overall incidence of endocarditis [6,7]. As an example, the incidence of IE in IDU in Philadelphia was estimated to be 5.3 cases/100,000 person-years, accounting for nearly one-half of all IE cases .
IE is more common in HIV-infected IDUs than in HIV-uninfected IDUs [4,8,9]. One case-control study among IDUs in Baltimore noted a fourfold higher incidence of IE in HIV-infected IDUs (13.8 versus 3.3 cases per 1000 person-years) . Lower CD4 counts were associated with a higher risk of IE in IDUs even after controlling for frequency of drug injection.
The incidence of IE in HIV-infected patients has declined with use of antiretroviral therapy. In one cohort of HIV-infected patients, the incidence of IE declined from 20 to 6 per 1000 person-years between the early and late 1990s .
- HUSSEY HH, KATZ S. Infections resulting from narcotic addiction; report of 102 cases. Am J Med 1950; 9:186.
- Sande MA, Lee BL, Mills J, et al. Endocarditis in intravenous drug users. In: Infective Endocarditis, Kaye D (Ed), Raven Press, New York City 1992. p.345.
- Weinstein WL, Brusch JL. Infective endocarditis, Oxford University Press, New York City 1996.
- Spijkerman IJ, van Ameijden EJ, Mientjes GH, et al. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol 1996; 49:1149.
- Welton DE, Young JB, Gentry WO, et al. Recurrent infective endocarditis: analysis of predisposing factors and clinical features. Am J Med 1979; 66:932.
- Berlin JA, Abrutyn E, Strom BL, et al. Incidence of infective endocarditis in the Delaware Valley, 1988-1990. Am J Cardiol 1995; 76:933.
- Bayer AS, Ward JI, Ginzton LE, Shapiro SM. Evaluation of new clinical criteria for the diagnosis of infective endocarditis. Am J Med 1994; 96:211.
- Manoff SB, Vlahov D, Herskowitz A, et al. Human immunodeficiency virus infection and infective endocarditis among injecting drug users. Epidemiology 1996; 7:566.
- Wilson LE, Thomas DL, Astemborski J, et al. Prospective study of infective endocarditis among injection drug users. J Infect Dis 2002; 185:1761.
- Gebo KA, Burkey MD, Lucas GM, et al. Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort. J Acquir Immune Defic Syndr 2006; 43:426.
- Mathew J, Addai T, Anand A, et al. Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med 1995; 155:1641.
- Pons-Lladó G, Carreras F, Borrás X, et al. Findings on Doppler echocardiography in asymptomatic intravenous heroin users. Am J Cardiol 1992; 69:238.
- Tuazon CU, Sheagren JN. Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis 1974; 129:725.
- Frontera JA, Gradon JD. Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. Clin Infect Dis 2000; 30:374.
- Chambers HF, Morris DL, Täuber MG, Modin G. Cocaine use and the risk for endocarditis in intravenous drug users. Ann Intern Med 1987; 106:833.
- DiNubile MJ. Abbreviated therapy for right-sided Staphylococcus aureus endocarditis in injecting drug users: the time has come? Eur J Clin Microbiol Infect Dis 1994; 13:533.
- Hecht SR, Berger M. Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes. Ann Intern Med 1992; 117:560.
- Ortiz-Bautista C, López J, García-Granja PE, et al. Current profile of infective endocarditis in intravenous drug users: The prognostic relevance of the valves involved. Int J Cardiol 2015; 187:472.
- Levine DP, Crane LR, Zervos MJ. Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study. Rev Infect Dis 1986; 8:374.
- Shekar R, Rice TW, Zierdt CH, Kallick CA. Outbreak of endocarditis caused by Pseudomonas aeruginosa serotype O11 among pentazocine and tripelennamine abusers in Chicago. J Infect Dis 1985; 151:203.
- Saydain G, Singh J, Dalal B, et al. Outcome of patients with injection drug use-associated endocarditis admitted to an intensive care unit. J Crit Care 2010; 25:248.
- Watanakunakorn C. Changing epidemiology and newer aspects of infective endocarditis. Adv Intern Med 1977; 22:21.
- Hubbell G, Cheitlin MD, Rapaport E. Presentation, management, and follow-up evaluation of infective endocarditis in drug addicts. Am Heart J 1981; 102:85.
- Bisbe J, Miro JM, Latorre X, et al. Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review. Clin Infect Dis 1992; 15:910.
- Miró JM, Puig de la Bellacasa J, Odds FC, et al. Systemic candidiasis in Spanish heroin addicts: a possible source of infection. J Infect Dis 1987; 156:857.
- Graves MK, Soto L. Left-sided endocarditis in parenteral drug abusers: recent experience at a large community hospital. South Med J 1992; 85:378.
- Dressler FA, Roberts WC. Infective endocarditis in opiate addicts: analysis of 80 cases studied at necropsy. Am J Cardiol 1989; 63:1240.
- Jain V, Yang MH, Kovacicova-Lezcano G, et al. Infective endocarditis in an urban medical center: association of individual drugs with valvular involvement. J Infect 2008; 57:132.
- Müller KA, Zürn CS, Patrik H, et al. Massive haemoptysis in an intravenous drug user with infective tricuspid valve endocarditis. BMJ Case Rep 2010; 2010.
- Ruotsalainen E, Sammalkorpi K, Laine J, et al. Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients. BMC Infect Dis 2006; 6:137.
- Chambers HF, Korzeniowski OM, Sande MA. Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts. Medicine (Baltimore) 1983; 62:170.
- Torres-Tortosa M, de Cueto M, Vergara A, et al. Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis. Grupo de Estudio de Enfermedades Infecciosas de la Provincia de Cádiz. Eur J Clin Microbiol Infect Dis 1994; 13:559.
- Small PM, Chambers HF. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 1990; 34:1227.
- Chambers HF, Miller RT, Newman MD. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med 1988; 109:619.
- Fortún J, Pérez-Molina JA, Añón MT, et al. Right-sided endocarditis caused by Staphylococcus aureus in drug abusers. Antimicrob Agents Chemother 1995; 39:525.
- Abrams B, Sklaver A, Hoffman T, Greenman R. Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers. Ann Intern Med 1979; 90:789.
- Ribera E, Gómez-Jimenez J, Cortes E, et al. Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial. Ann Intern Med 1996; 125:969.
- Markowitz N, Quinn EL, Saravolatz LD. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med 1992; 117:390.
- Dworkin RJ, Lee BL, Sande MA, Chambers HF. Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet 1989; 2:1071.
- Heldman AW, Hartert TV, Ray SC, et al. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med 1996; 101:68.
- Arbulu A, Holmes RJ, Asfaw I. Surgical treatment of intractable right-sided infective endocarditis in drug addicts: 25 years experience. J Heart Valve Dis 1993; 2:129.
- Rabkin DG, Mokadam NA, Miller DW, et al. Long-term outcome for the surgical treatment of infective endocarditis with a focus on intravenous drug users. Ann Thorac Surg 2012; 93:51.
- Thalme A, Westling K, Julander I. In-hospital and long-term mortality in infective endocarditis in injecting drug users compared to non-drug users: a retrospective study of 192 episodes. Scand J Infect Dis 2007; 39:197.
- Menda KB, Gorbach SL. Favorable experience with bacterial endocarditis in heroin addicts. Ann Intern Med 1973; 78:25.
- DiNubile MJ. Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users. Ann Intern Med 1994; 121:873.
- Mathew J, Abreo G, Namburi K, et al. Results of surgical treatment for infective endocarditis in intravenous drug users. Chest 1995; 108:73.
- Martín-Dávila P, Navas E, Fortún J, et al. Analysis of mortality and risk factors associated with native valve endocarditis in drug users: the importance of vegetation size. Am Heart J 2005; 150:1099.
- Robbins MJ, Frater RW, Soeiro R, et al. Influence of vegetation size on clinical outcome of right-sided infective endocarditis. Am J Med 1986; 80:165.
- Bayer AS, Blomquist IK, Bello E, et al. Tricuspid valve endocarditis due to Staphylococcus aureus. Correlation of two-dimensional echocardiography with clinical outcome. Chest 1988; 93:247.
- Ribera E, Miró JM, Cortés E, et al. Influence of human immunodeficiency virus 1 infection and degree of immunosuppression in the clinical characteristics and outcome of infective endocarditis in intravenous drug users. Arch Intern Med 1998; 158:2043.
- Alagna L, Park L, Nicholson B, et al. Repeat endocarditis – a consequence of medical progress? Analysis of risk factors based on International Collaboration on Endocarditis – Prospective Cohort Study (ICE-PCS). Clin Microbiol Infect 2012; 18:22.
- Chu VH, Sexton DJ, Cabell CH, et al. Repeat infective endocarditis: differentiating relapse from reinfection. Clin Infect Dis 2005; 41:406.